Clinical Trials Directory

Trials / Completed

CompletedNCT02547272

Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus

Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus in a Cohort of Adult Patients Hospitalized in Intensive Care at the University Hospital of St Etienne.

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nasal colonization with S. aureus is a risk factor for infection with this bacterium. A methodologically well conducted study of S. aureus bacteremia showed that 80% of S. aureus bacteremia with are due to the strain isolated in the nasal level. However, as part of a study coordinated by the CHU of Saint-Etienne, less than 50% of infections in prosthetic orthopedic devices have been linked to nasal carriage . Outside of exogenous infections, intestinal colonization with S. aureus could be an alternative source of endogenous infections with the waning of orthopedic surgery. In the general population, considering that about one third of the subjects were colonized with S. aureus nasal level and 1 in 5 in the intestine However the proportion of exclusive intestinal porting is not well known . This study will analyze, among ICU patients, porting S. aureus nasal and rectal level. It will better clarify the relationship between nasal and rectal ports and the risk of developing an infection.

Detailed description

The adult patients hospitalized in intensive care at the University Hospital of Saint-Etienne have a multiresistant bacteria porting screening at the nose and rectum at admission and then once a week. These samples will be carried unchanged way for the study but will also be a research S Aureus

Conditions

Interventions

TypeNameDescription
PROCEDURENasal and rectal bacterial samplesBacterial nasal and rectal samples at admission and one weekly for the presence of S Aureus

Timeline

Start date
2013-02-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2015-09-11
Last updated
2016-03-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02547272. Inclusion in this directory is not an endorsement.